Skip to main content

Advertisement

Log in

Interaction of psychological factors and the effect of epoetin alfa treatment in cancer patients on hemoglobin and fatigue

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Introduction and background

Epoetin alfa is known to produce a hematological response in anemic cancer patients. A concomitant reduction in fatigue as well as an improvement of depression and anxiety and of quality of life has been reported. However, these effects are discussed controversially. Psychological variables may have a moderating effect on fatigue reduction.

Materials and methods

Fifty-four anemic cancer outpatients were treated with epoetin alfa over 26 weeks with an initial dose of 3×10,000 IU/week and further individually adapted dosage. Hemoglobin level, fatigue, depression, anxiety, and health-related quality of life were measured every 4 weeks.

Results

The hematological response rate was 50%, with 1/3 occurring after more than 8 weeks of treatment. Fatigue, depression, and quality of life improved significantly. Reduction in fatigue was associated with response, but the correlations between fatigue and hemoglobin were weak. Less depression and higher quality of life before treatment correlated with a better fatigue reduction when controlling for hemoglobin increase and initial fatigue level.

Conclusion

Psychological variables influence the reduction of fatigue during therapy with epoetin alfa in anemic cancer patients and should therefore be assessed at the beginning of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  PubMed  CAS  Google Scholar 

  2. Barnes EA, Bruera E (2002) Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer 12:424–428

    Article  PubMed  CAS  Google Scholar 

  3. Bohlius J, Langensiepen S, Schwarzer G, Seidenfeld J, Piper M, Bennet C, Engert A (2004) Erythropoietin for patients with malignant disease (Cochrane review). In: The Cochrane library, Issue 3. Wiley, Chichester

  4. Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P (2004) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 40:2201–2216

    Article  PubMed  CAS  Google Scholar 

  5. Cella D, Jin-Shei L, Chih-Hung C, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94:528–538

    Article  PubMed  Google Scholar 

  6. Cella D, Zagari MJ, Vandoros C, Gagnon DD, Hurtz HJ, Nortier JWR (2003) Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 21:366–373

    Article  PubMed  Google Scholar 

  7. Cella D, Kallich J, McDermott A, Xu X (2004) The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 15:979–986

    Article  PubMed  CAS  Google Scholar 

  8. Glaus A (1998) Fatigue in patients with cancer—analysis and assessment. Recent results in cancer research. Springer, Berlin Heidelberg New York 145:54–76

  9. Herrmann C, Buss U, Snaith RP (1993) HADS-D: hospital anxiety and depression scale (German version). Huber, Bern

    Google Scholar 

  10. Kallich JD, Tchekmedyian NS, Damiano AM, Shi J, Black JT, Erder MH (2002) Psychological outcomes associated with anemia-related fatigue in cancer patients. Oncology (Williston Park) 16(9 Suppl 10):117–124

    Google Scholar 

  11. Lipman AJ, Lawrence DP (2004) The management of fatigue in cancer patients. Oncology (Williston Park) 18:1527–1535

    Google Scholar 

  12. Littlewood TJ, Zagari M, Pallister C, Perkins A (2003) Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patients. Oncologist 8:99–107

    Article  PubMed  CAS  Google Scholar 

  13. Ludwig H, Fritz E (1998) Anemia in cancer patients: patient selection and patient stratification for epoetin treatment. Semin Oncol 25:2–6

    PubMed  CAS  Google Scholar 

  14. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C, National Comprehensive Cancer Network (2000) NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) 14:151–161

    CAS  Google Scholar 

  15. Nowrousian M, Kasper C, Oberhoff C (1996) Pathophysiology of cancer-related anemia. In: Smyth JF, Boogaerts MA, Ehmer BRM (eds) rhErythropoietin in cancer supportive treatment. Marcel Dekker, New York

    Google Scholar 

  16. Osterborg A, Boogaerts MA, Cimino R, Essers U, Holowiecki J, Juliusson G, Jager G, Najman A, Peest D for The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin’s Lymphoma (1996) Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin’s lymphoma—a randomized multicenter study. Blood 87:2675–2682

    PubMed  CAS  Google Scholar 

  17. Simon AN, Zittoun R (1999) Fatigue in cancer patients. Curr Opin Oncol 11:244–249

    Article  PubMed  CAS  Google Scholar 

  18. Stone P, Richards M, Hardy J (1998) Fatigue in patients with cancer. Eur J Cancer 34:1670–1677

    Article  PubMed  CAS  Google Scholar 

  19. Tchekmedyian NS, Kallich J, McDermott A, Fayers P, Erder MH (2003) The relationship between psychologic distress and cancer-related fatigue. Cancer 98:198–203

    Article  PubMed  Google Scholar 

  20. Vogelzang N, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK (1997) Patient, caregiver and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol 34:4–12

    PubMed  CAS  Google Scholar 

  21. Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We wish to thank Mrs. Susanne Herz for her effective work in patient coordination and data collection. The Leukämie-Initiative Bonn e.V. supports the research work of the group continuously. The study was supported by an unrestricted research grant from Ortho-Biotech/Janssen-Cilag, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Franziska Geiser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geiser, F., Hahn, C., Conrad, R. et al. Interaction of psychological factors and the effect of epoetin alfa treatment in cancer patients on hemoglobin and fatigue. Support Care Cancer 15, 273–278 (2007). https://doi.org/10.1007/s00520-006-0132-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-006-0132-8

Keywords

Navigation